1. Home
  2. JBLU vs NTLA Comparison

JBLU vs NTLA Comparison

Compare JBLU & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBLU
  • NTLA
  • Stock Information
  • Founded
  • JBLU 1998
  • NTLA 2014
  • Country
  • JBLU United States
  • NTLA United States
  • Employees
  • JBLU N/A
  • NTLA N/A
  • Industry
  • JBLU Air Freight/Delivery Services
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • JBLU Consumer Discretionary
  • NTLA Health Care
  • Exchange
  • JBLU Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • JBLU 2.0B
  • NTLA 1.4B
  • IPO Year
  • JBLU N/A
  • NTLA 2016
  • Fundamental
  • Price
  • JBLU $6.94
  • NTLA $16.11
  • Analyst Decision
  • JBLU Hold
  • NTLA Buy
  • Analyst Count
  • JBLU 10
  • NTLA 17
  • Target Price
  • JBLU $6.31
  • NTLA $57.25
  • AVG Volume (30 Days)
  • JBLU 19.7M
  • NTLA 3.0M
  • Earning Date
  • JBLU 10-29-2024
  • NTLA 11-07-2024
  • Dividend Yield
  • JBLU N/A
  • NTLA N/A
  • EPS Growth
  • JBLU N/A
  • NTLA N/A
  • EPS
  • JBLU N/A
  • NTLA N/A
  • Revenue
  • JBLU $9,327,000,000.00
  • NTLA $43,086,000.00
  • Revenue This Year
  • JBLU N/A
  • NTLA $50.73
  • Revenue Next Year
  • JBLU $5.55
  • NTLA $8.69
  • P/E Ratio
  • JBLU N/A
  • NTLA N/A
  • Revenue Growth
  • JBLU N/A
  • NTLA N/A
  • 52 Week Low
  • JBLU $4.09
  • NTLA $13.95
  • 52 Week High
  • JBLU $8.07
  • NTLA $34.87
  • Technical
  • Relative Strength Index (RSI)
  • JBLU 57.91
  • NTLA 42.72
  • Support Level
  • JBLU $6.25
  • NTLA $15.61
  • Resistance Level
  • JBLU $6.47
  • NTLA $17.83
  • Average True Range (ATR)
  • JBLU 0.34
  • NTLA 0.99
  • MACD
  • JBLU 0.02
  • NTLA 0.21
  • Stochastic Oscillator
  • JBLU 71.94
  • NTLA 55.67

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The operating segments of company are Domestic & Canada, Caribbean & Latin America and Atlantic. Majority of revenue is generated from Domestic & Canada segment.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: